Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 10/20 | 0.57 |
| ▸ | PPARG | P37231 | 7/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.53 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8975403 | 0.94 | FFAR1 (0.60) | FFAR1PPARGCYP1A2ADRB2ADRB1 | |
| SCHEMBL8974734 | 0.86 | FFAR1 (0.56) | FFAR1PPARGADRB2ADRB1ADRB3 | |
| SCHEMBL8975281 | 0.85 | PPARG (0.54) | FFAR1PPARGCYP1A2ADRB2ADRB1 | |
| SCHEMBL7173016 | 0.85 | FFAR1 (0.58) | FFAR1PPARGADRB2ADRB1ADRB3 | |
| SCHEMBL8974677 | 0.80 | PPARG (0.57) | FFAR1PPARGCYP1A2ADRB2ADRB1 | |
| SCHEMBL8974743 | 0.80 | FFAR1 (0.59) | FFAR1PPARGPPARA | |
| SCHEMBL1299621 | 0.79 | FFAR1 (0.83) | FFAR1PPARGCYP1A2PPARA | |
| SCHEMBL7695772 | 0.79 | ADRB1 (0.54) | ADRB2ADRB1ADRB3 | |
| SCHEMBL7122566 | 0.79 | ADRB1 (0.54) | ADRB2ADRB1ADRB3 | |
| SCHEMBL1072226 | 0.77 | FFAR1 (0.77) | FFAR1PPARGCYP1A2PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5578620-A | TREATMENT OF DIABETES AND HYPERLIPEMIA | SANKYO COMPANY, LIMITED (JP) | 1996-11-26 | — | — | US | disclosed |
| EP-0678511-A2 | Thiazolidine and oxazolidine derivatives, their preparation and their medical use | SANKYO COMPANY LIMITED (JP) | 1995-10-25 | — | — | EP | disclosed |